PYC THERAPEUTICS LIMITED — Director's Dealing 2012

Dec 2, 2012

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PHYLOGICA LIMITED ABN 48 098 391 961

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	PAUL MICHAEL WATT
Date of last notice	8 AUGUST 2012

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	INDIRECT
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	PAUL MICHAEL WATT & MARIA DELPILARENRIQUEZ‐WATTATFTHEBRAINCHILD SUPER FUNDTrustee & Fund Beneficiary
**Date of change **	30 NOVEMBER 2012
No. of securities held prior to change	DIRECT‐ 4,044,123 ORDINARY SHARESINDIRECT‐ 12,384,607 ORDINARY SHARES‐ 1,500,000 UNLISTED OPTIONS AT$0.075 EXPIRING 31/03/13‐ 169,466 QUOTED OPTIONS AT $0.09EXPIRING30/06/16
Class	CONVERTING NOTEUNLISTED OPTIONS
Number acquired	50 CONVERTING NOTE2,250,000 OPTIONS
Nature of changeExample: on‐market trade, off‐market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy‐back	PLACEMENT PURSUANT TOSHAREHOLDER APPROVAL ACQUIRED22/11/2012
Value/ConsiderationNote: If consideration is non‐cash, provide details and estimatedvaluation	$100 PER CONVERTING NOTEOPTIONS ISSUED FREE

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	DIRECT‐ 4,044,123 ORDINARY SHARESINDIRECT‐ 12,384,607 ORDINARY SHARES‐ 1,500,000 UNLISTED OPTIONS AT$0.075 EXPIRING 31/03/13‐ 2,250,000 UNLISTED OPTIONS AT NILEXERCISE PRICE EXPIRING 02/12/13‐ 169,466 QUOTED OPTIONS AT $0.09EXPIRING 30/06/16‐ 50 CONVERTING NOTESCONVERTING 02/12/13

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [433 x 207] intentionally omitted <==

----- Start of picture text ----- Detail of contractNature of interestName of registered holder(if issued securities)Date of changeNo. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changedInterest acquiredInterest disposedValue/ConsiderationNote: If consideration is non‐cash, provide detailsand an estimated valuationInterest after change----- End of picture text -----

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	NO
If so, was prior written clearance provided to allow the tradeto proceed during this period?	N/A
If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011